Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-102510
Filing Date
2010-11-08
Accepted
2010-11-08 16:42:04
Documents
6
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y04168e10vq.htm 10-Q 207383
2 EX-10.2 y04168exv10w2.htm EX-10.2 54565
3 EX-31.1 y04168exv31w1.htm EX-31.1 8616
4 EX-31.2 y04168exv31w2.htm EX-31.2 8603
5 EX-32.1 y04168exv32w1.htm EX-32.1 3148
6 EX-32.2 y04168exv32w2.htm EX-32.2 3156
  Complete submission text file 0000950123-10-102510.txt   287129
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 101172885
SIC: 2836 Biological Products, (No Diagnostic Substances)